Zhejiang Xianju Pharmaceutical Co Ltd (002332) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Xianju Pharmaceutical Co Ltd (002332) has a cash flow conversion efficiency ratio of 0.022x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥130.05 Million ≈ $19.03 Million USD) by net assets (CN¥6.03 Billion ≈ $881.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Xianju Pharmaceutical Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
Zhejiang Xianju Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Zhejiang Xianju Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 002332 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Xianju Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Xianju Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Inmyshow Digital Technology Group Co Ltd
SHG:600556
|
0.039x |
|
Via Transportation, Inc.
NASDAQ:VIA
|
-0.034x |
|
Poongsan
KO:103140
|
0.019x |
|
Techno Electric & Engineering Company Limited
NSE:TECHNOE
|
-0.042x |
|
Alexanders Inc
NYSE:ALX
|
0.075x |
|
secunet Security Networks Aktiengesellschaft
F:YSN
|
-0.009x |
|
Hornbach Holding VZO O.N.
XETRA:HBH
|
0.016x |
|
Anhui Shanying Paper Industry Co Ltd
SHG:600567
|
0.050x |
Annual Cash Flow Conversion Efficiency for Zhejiang Xianju Pharmaceutical Co Ltd (2006–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Xianju Pharmaceutical Co Ltd from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see 002332 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥6.08 Billion ≈ $890.00 Million |
CN¥247.48 Million ≈ $36.21 Million |
0.041x | -39.90% |
| 2024-12-31 | CN¥5.89 Billion ≈ $861.62 Million |
CN¥398.66 Million ≈ $58.34 Million |
0.068x | -33.71% |
| 2023-12-31 | CN¥5.83 Billion ≈ $853.12 Million |
CN¥595.48 Million ≈ $87.14 Million |
0.102x | -7.67% |
| 2022-12-31 | CN¥5.51 Billion ≈ $805.91 Million |
CN¥609.28 Million ≈ $89.16 Million |
0.111x | -19.09% |
| 2021-12-31 | CN¥4.94 Billion ≈ $723.59 Million |
CN¥676.15 Million ≈ $98.94 Million |
0.137x | -20.61% |
| 2020-12-31 | CN¥4.58 Billion ≈ $670.54 Million |
CN¥789.23 Million ≈ $115.49 Million |
0.172x | +1.34% |
| 2019-12-31 | CN¥3.06 Billion ≈ $447.57 Million |
CN¥519.81 Million ≈ $76.06 Million |
0.170x | +138.33% |
| 2018-12-31 | CN¥2.71 Billion ≈ $396.60 Million |
CN¥193.27 Million ≈ $28.28 Million |
0.071x | +1.60% |
| 2017-12-31 | CN¥2.39 Billion ≈ $349.14 Million |
CN¥167.47 Million ≈ $24.51 Million |
0.070x | +0.71% |
| 2016-12-31 | CN¥2.24 Billion ≈ $327.35 Million |
CN¥155.91 Million ≈ $22.81 Million |
0.070x | -24.84% |
| 2015-12-31 | CN¥2.15 Billion ≈ $314.98 Million |
CN¥199.61 Million ≈ $29.21 Million |
0.093x | -19.61% |
| 2014-12-31 | CN¥1.23 Billion ≈ $179.69 Million |
CN¥141.64 Million ≈ $20.73 Million |
0.115x | +114.84% |
| 2013-12-31 | CN¥1.18 Billion ≈ $172.97 Million |
CN¥63.46 Million ≈ $9.29 Million |
0.054x | +93.15% |
| 2012-12-31 | CN¥1.20 Billion ≈ $175.98 Million |
CN¥33.43 Million ≈ $4.89 Million |
0.028x | -78.28% |
| 2011-12-31 | CN¥1.15 Billion ≈ $168.80 Million |
CN¥147.63 Million ≈ $21.60 Million |
0.128x | -7.59% |
| 2010-12-31 | CN¥1.12 Billion ≈ $164.09 Million |
CN¥155.29 Million ≈ $22.72 Million |
0.138x | +45.55% |
| 2009-12-31 | CN¥1.10 Billion ≈ $160.99 Million |
CN¥104.68 Million ≈ $15.32 Million |
0.095x | +7.10% |
| 2008-12-31 | CN¥405.55 Million ≈ $59.34 Million |
CN¥36.03 Million ≈ $5.27 Million |
0.089x | -63.11% |
| 2007-12-31 | CN¥400.83 Million ≈ $58.65 Million |
CN¥96.53 Million ≈ $14.13 Million |
0.241x | +77.49% |
| 2006-12-31 | CN¥390.97 Million ≈ $57.21 Million |
CN¥53.05 Million ≈ $7.76 Million |
0.136x | -- |
About Zhejiang Xianju Pharmaceutical Co Ltd
Zhejiang Xianju Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of steroid raw materials and preparations in China and internationally. The company offers gynecological, anesthesia, respiratory, dermatology, generic drug, and other products; active pharmaceutical ingredients (API), such as corticosteroids, sex hormone, progestero… Read more